IL10 and lung carcinoma: Based on published data that miR-98 can inhibit IL-10 expression in macrophages12, the phenomenon of high frequency of B10 cells in cancer patients implicates that the miR-98 expression in B cells of lung cancer patients may be dysfunctional.